Latest News by Industry
By Shubhangi Mathur, 5 PM ET
•FDA says two doses of vaccine enough to provide protection against hospitalization and death due to coronavirus
•Last month, FDA refrained from taking a stance on Pfizer’s COVID-19 booster shots as well
Food and Drug Administration scientists on Tuesday denied to take a stance on supporting COVID-19 booster shots of Moderna.
According to data, the FDA scientists said, two doses of vaccine are enough to provide protection against hospitalization and death due to coronavirus.
“Some real world effectiveness studies have suggested declining efficacy of Moderna COVID-19 Vaccine over time against symptomatic infection or against the Delta variant, while others have not,” they wrote in a 45-page document published on the agency’s website.
“However, overall, data indicate that currently US-licensed or authorized COVID-19 vaccines still afford protection against severe COVID-19 disease and death in the United States.”
Last month, FDA refrained from taking stance on Pfizer’s Covid booster shots as well.
The report by FDA scientists will be used in committee’s meeting on Thursday to review Moderna’s request for booster doses.
FDA had approved Covid booster shots by Pfizer last month which will be used for the elderly, adults with underlying medical conditions, and those who work or live in high-risk settings like health and grocery workers.
Moderna applied for authorization of its booster dose to FDA on September 1 claiming the dose was safe and produced stronger immune response than the one produced by the second dose in its phase three clinical trial.
Moderna is requesting FDA to allow its boosters for the same groups as allowed for Pfizer. Moderna said that side effects of boosters are comparable to those of second dose.
The Biden administration expects that these additional doses will provide long-term protection against hospitalization and death due to the spread of delta variant.
Picture Credits: Getty Images